Ototoxicity following Vinblastine chemotherapy in a patient of Hodgkin's Lymphoma

Sudden hearing loss is a well-known complication of certain chemotherapeutic agents. However, vinblastine has seldom been implicated causing ototoxicity. We report a case of sudden bilateral hearing loss in a 36-year-old male patient of Mixed cellularity Hodgkin's lymphoma following standard adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy.